Skip to main content
Melvin Spigelman, MD, Oncology, Bronx, NY

MelvinKalmanSpigelmanMD

Oncology Bronx, NY

President & CEO, Global Alliance for TB Drug Development, NY, NY 10005

Dr. Spigelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Spigelman's full profile

Already have an account?

  • Office

    4655 Douglas Ave
    Bronx, NY 10471
    Phone+1 718-432-7572
    Fax+1 718-432-7572

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Medical Oncology, 1977 - 1980
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Public Health and General Preventive Medicine, 1977 - 1979
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1974 - 1977
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1976 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • American Board of Preventive Medicine General Preventive Medicine

Publications & Presentations

PubMed

Press Mentions

  • New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases: Study
    New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases: StudyMarch 4th, 2020